Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Japanese researchers describe analgesic tripeptides

Dec. 31, 1996

First phase II results for Innapharma's peptide antidepressant

Dec. 30, 1996

New agents for CNS disorders claimed by HHS

Dec. 30, 1996

Copaxone approved by FDA

Dec. 24, 1996

AACTG begins phase II memantine trial

Dec. 24, 1996

T Cell Sciences reports progress on TCAR program

Dec. 24, 1996

Otsuka describes new analgesics

Dec. 24, 1996

Neuroprotective polypeptide reported by Amgen

Dec. 24, 1996

Algos and Interneuron codevelop novel antimigraine combination

Dec. 23, 1996

Northwest Neurologic and Wyeth-Ayerst neurodegenerative disorder collaboration

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...